tallózása szerző szerint "Hruschka N"

A találatok rendezése: Rendezés: Találatok:

  • Afatinib restrains K-RAS-driven lung tumorigenesis 
    Moll HP; Pranz K; Musteanu M; Grabner B; Hruschka N; Mohrherr J; Aigner P; Stiedl P; Brcic L; Laszlo, Viktoria; Schramek D; Moriggl R; Eferl R; Moldvay, Judit; Dezső, Katalin; Lopez-Casas PP; Stoiber D; Hidalgo M; Penninger J; Sibilia M; Győrffy, Balázs; Barbacid M; Döme, Balázs; Popper H; Casanova E (2018)
    On the basis of clinical trials using first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), it became a doctrine that V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (K-RAS) ...
  • Disruption of STAT3 signaling promotes KRAS induced lung tumorigenesis 
    Grabner B; Schramek D; Mueller KM; Moll HP; Svinka J; Hoffmann T; Bauer E; Blaas L; Hruschka N; Zboray K; Stiedl P; Nivarthi H; Bogner E; Gruber W; Mohr T; Zwick RH; Kenner L; Poli V; Aberger F; Stoiber D; Egger G; Esterbauer H; Zuber J; Moriggl R; Eferl R; Győrffy, Balázs; Penninger JM; Popper H; Casanova E (2015)